Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Mikko Karppa"'
Autor:
Henna Härkönen, Kirsi Myllykangas, Mikko Kärppä, Kirsi Maaria Rasmus, Julius Francis Gomes, Milla Immonen, Piia Hyvämäki, Miia Jansson
Publikováno v:
Journal of Medical Internet Research, Vol 26, p e52715 (2024)
BackgroundCerebrovascular diseases (CVDs) are a major and potentially increasing burden to public health. Digital health interventions (DHIs) could support access to and provision of high-quality health care (eg, outcomes, safety, and satisfaction),
Externí odkaz:
https://doaj.org/article/78b6f4c820124f84ad8be40207390cac
Autor:
Antoinette MaassenVanDenBrink, Gisela M. Terwindt, Joshua M. Cohen, Steve Barash, Verena Ramirez Campos, Maja Galic, Xiaoping Ning, Mikko Kärppä
Publikováno v:
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-14 (2021)
Abstract Background Migraine prevalence is age and sex dependent, predominating in women in early and middle adulthood; however, migraine also represents a substantial burden for men and adults of all ages. Thus, understanding this burden and the eff
Externí odkaz:
https://doaj.org/article/3aa93823035d49df961e4babee9f0114
Autor:
Egilius L. H. Spierings, Mikko Kärppä, Xiaoping Ning, Joshua M. Cohen, Verena Ramirez Campos, Ronghua Yang, Uwe Reuter
Publikováno v:
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-12 (2021)
Abstract Background The FOCUS study evaluated the efficacy of migraine preventive medications across different countries within the same patient population, particularly for patients with difficult-to-treat migraine. These prespecified subgroup analy
Externí odkaz:
https://doaj.org/article/8fb2e15f724647799b90d9afe86d3a83
Mutation m.15923A>G in the MT-TT gene causes mild myopathy – case report of an adult-onset phenotype
Publikováno v:
BMC Neurology, Vol 18, Iss 1, Pp 1-5 (2018)
Abstract Background Only five patients have previously been reported to harbor mutations in the MT-TT gene encoding mitochondrial tRNA threonine. The m.15923A > G mutation has been found in three severely affected children. One of these patients died
Externí odkaz:
https://doaj.org/article/1cbec44a9ed74328ba1a1ecc943c5ab9
Autor:
Laura Kytövuori, Mikko Kärppä, Hannu Tuominen, Johanna Uusimaa, Markku Saari, Reetta Hinttala, Kari Majamaa
Publikováno v:
BMC Neurology, Vol 17, Iss 1, Pp 1-5 (2017)
Abstract Background Mitochondrial cytochrome c oxidase 2, MT-CO2, encodes one of the three subunits, which form the catalytic core of cytochrome c oxidase (COX), complex IV. Mutations in MT-CO2 are rare and the associated phenotypes are variable incl
Externí odkaz:
https://doaj.org/article/5744b13c908949dbb28a0b71f16b9a68
Publikováno v:
Neurology International, Vol 1, Iss 1, Pp e7-e7 (2009)
Amyloid myopathy (AM) is a rare manifestation of primary systemic amyloidosis (AL). Like inflammatory myopathies, it presents with proximal muscle weakness and an increased creatine kinase level. We describe a case of AL with severe, rapidly progress
Externí odkaz:
https://doaj.org/article/00772bff884742268b45f1360e28f4ef
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-8 (2024)
Abstract Background Multimorbidity is common in elderly people, and one of the major consequences of multimorbidity is low health-related quality of life (HRQoL). The aim of this study was to investigate the frequency of comorbid diseases in patients
Externí odkaz:
https://doaj.org/article/d4903cf6e5af4575bd76e86be7997202
Publikováno v:
BMJ Neurology Open, Vol 6, Iss 2 (2024)
Background The m.3243A>G variant in mitochondrial DNA (mtDNA) is the most common cause of the MELAS (Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes) syndrome usually commencing in childhood or adolescence. In adults, the varia
Externí odkaz:
https://doaj.org/article/185136fa0b004cab83c323c82ff50399
Autor:
Mikko Karppa, Marja-Liisa Sumelahti, Osmo Suovaniemi, Markus Färkkilä, Minna Maki, Lea Paloheimo, Kari Syrjänen, Mikko Kallela, Matti Ilmavirta, Markku Nissilä, Petra Keski-Säntti
Publikováno v:
Clinical Case Studies and Reports. 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab238c3eac1711e79a111369cd03cd18
https://doi.org/10.15761/ccsr.1000167
https://doi.org/10.15761/ccsr.1000167
Autor:
Sammeli Liikkanen, Janne Sinkkonen, Joni Suorsa, Valtteri Kaasinen, Eero Pekkonen, Mikko Kärppä, Filip Scheperjans, Teppo Huttunen, Toni Sarapohja, Ullamari Pesonen, Mikko Kuoppamäki, Tapani Keränen
Publikováno v:
PLOS Digital Health, Vol 2, Iss 4, p e0000225 (2023)
In the quantification of symptoms of Parkinson's disease (PD), healthcare professional assessments, patient reported outcomes (PRO), and medical device grade wearables are currently used. Recently, also commercially available smartphones and wearable
Externí odkaz:
https://doaj.org/article/012d6c5856004986a94efd8d4883e5a0